Deadline Reminder: If you are a member of the proposed Class, you may move the court no later than August 5, 2024 to serve as a lead plaintiff for the purported class. If you have losses we encourage you ...
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Company had deficiencies in its quality assuranc...
US case lawcould allow Ripple to address allegations of breaching securities laws after the complaint. In Morrison vs. NAB, the US Supreme Court ruled the SEC only has jurisdiction over US-based sales. If Ripple can demonstrate all post-complaint sales were outside the US, the court could ...
If you are a member of the proposed Class, you may move the court no later than May 31, 2024 to serve as lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn mo...
Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Alibaba you have until January 12, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead ...
Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and ...
plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead ...
plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead ...
Specifically, on December 17, 2020, the Securities and Exchange Commission ("SEC") filed a complaint in federal court against Defendants, alleging that they had issued a series of press releases that falsely claimed that Decision Diagnostics had developed a finger-prick blood test that could detect...
As detailed below, the complaintallegesthat the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that Vicor had secured a significant deal for its H100 product that, according to analy...